Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Small Cell Lung Carcinoma × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

apatinib 4 Etoposide 3 surufatinib 2 Topotecan 2 Simvastatin 2 Irinotecan 2 Carboplatin 2 nintedanib 1 camrelizumab 1 anlotinib 1 Tomography, X-Ray Computed 1 Sunitinib 1 Sorafenib 1 Radiotherapy 1 Paclitaxel 1 PE regimen 1 Lithium 1 Immunotherapy 1 Ifosfamide 1 Gemcitabine 1 EC regimen 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01441297 2017-08-25

BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡